NPPA Fixes Retail Prices of 69 Formulations, Details
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 69 formulations including antidiabetic drugs, cardiovascular drugs, cholesterol-lowering drugs bacterial infections, etc.This came in line with the decision of the 121st Authority Meeting dated 20.2.2024.This includes Synokem Pharmaceuticals/Mankind Pharma's...
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of the 69 formulations including antidiabetic drugs, cardiovascular drugs, cholesterol-lowering drugs bacterial infections, etc.
This came in line with the decision of the 121st Authority Meeting dated 20.2.2024.
This includes Synokem Pharmaceuticals/Mankind Pharma's Sitagliptin and Metformin, Pure and Cure Healthcare and Blue Cross Laboratories Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide, Pure and Cure Healthcare and Blue Cross Laboratories's Telmisartan, Amlodipine Hydrochlorothiazide, Mascot Health and Biological E's Paracetamol Phenylephrine HCL and Chlorpheniramine Maleate Syrup, other.
The notice further stated that in the exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3),(4) and (5) thereof;
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Sitagliptin and Metformin Hydrochloride Extended-Release Tablets | Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (As extended-release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 13.25 |
2 | Olmesartan Medoxomil, Amlodipine &Hydrochloroth iazideTablet | Each film coated tablet contains: Olmesartan Medoxomil IP 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Blue Cross Laboratories Private Limited | 8.92 |
3 | Olmesartan Medoxomil, Amlodipine &Hydrochloroth iazideTablet | Each film coated tablet contains: Olmesartan Medoxomil IP 40mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Blue Cross Laboratories Private Limited | 10.71 |
4 | Telmisartan, Amlodipine & Hydrochlorothia zide Tablet | Each film-coated tablet contains: Telmisartan IP 80mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Mankind Pharma Ltd. | 16.24 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
12.5mg | |||||
5 | Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate Syrup | Each 5ml contains: Paracetamol IP 125mg Phenylephrine HCl IP 5.0mg Chlorpheniramine Maleate IP 1.0mg | 1 ml | M/s Mascot Health Series Pvt. Ltd. / M/s Biological E. Limited | 1.06 |
6 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | Each 5ml contains: Phenylephrine Hydrochloride IP 5.0mg Chlorpheniramine Maleate IP 2.0mg | 1 ml | M/s Windlas Biotech Limited / M/s Biological E. Limited | 1.22 |
7 | Chlorphenirami ne Maleate, Dextromethorph an Hydrobromide & Phenylephrine Hydrochloride Syrup | Each 5ml contains: Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg Dextromethorphan Hydrobromide IP 15mg | 1 ml | M/s Yacca Lifesciences Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 0.94 |
8 | Escitalopram Oxalate Tablets | Each film-coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 15mg | 1 Tablet | M/s Lupin Limited | 11.84 |
9 | Amoxycillin and Potassium Clavulanate Oral Suspension | Each 5ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57mg | 1 ml | M/s Brooks Laboratories Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 4.22 |
10 | Cefixime and Ofloxacin Tablets | Each film-coated tablet contains: Cefixime IP (As Trihydrate) eq. to Anhydrous Cefixime 200mg Ofloxacin IP 200mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 13.87 |
11 | Paracetamol Paediatric Oral Suspension | Each 1ml contains: Paracetamol IP 100mg | 1 ml | M/s Aristo Pharmaceuticals Pvt. Ltd. | 1.62 |
12 | Chlorphenirami ne Maleate, Dextromethorph an Hydrobromide & Phenylephrine Hydrochloride Syrup | Each 5ml contains: Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg Dextromethorphan Hydrobromide IP 10mg | 1 ml | M/s Yacca Lifesciences Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 0.99 |
13 | Clopidogrel & Aspirin Tablets | Each uncoated bilayered tablet contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies | 4.85 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Aspirin IP 150mg | Pharmaceuticals Private Limited | ||||
14 | Meropenem and Sulbactam for Injection | Each vial contains: Meropenem IP eq. to Anhydrous Meropenem 1000mg (A Sterile Mixture of meropenem & Sodium Carbonate (Sodium 90.2mg) Sulbactam Sodium IP eq. to Anhydrous Sulbactam 500mg | 1 Vial | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 1598.7 5 |
15 | Olmesartan Medoxomil, Hydrochlorothia zide & Amlodipine Tablet | Each film-coated tablet contains: Olmesartan Medoxomil IP 20mg Hydrochlorothiazide IP 12.5mg Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 14.52 |
16 | Cefpodoxime & Potassium Clavulanate Oral suspension | Each 5ml reconstituted suspension contains: Cefpodoxime Proxetil IP eq. to Anhydrous Cefpodoxime 50mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 31.25mg | 1 ml | M/s Saitech Medicare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 3.10 |
17 | Cefuroxime Axetil& Potassium Clavulanate Tablets | Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime 500mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg | 1 Tablet | M/s Saitech Medicare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 56.98 |
18 | Telmisartan & Chlorthalidone Tablet | Each uncoated bi-layer tablet contains: Telmisartan IP 80mg Chlorthalidone 6.25mg | 1 Tablet | M/s Aristo Pharmaceuticals Pvt. Ltd. | 17.74 |
19 | Trypsin, Bromelain, Rutoside Trihydrate, and Diclofenac Sodium Tablets | Each enteric-coated tablet contains: Trypsin BP 48mg Bromelain 90mg Rutoside Trihydrate BP 100mg Diclofenac Sodium IP 50mg | 1 Tablet | M/s Synokem Pharmaceutical Ltd./ M/s Intas Pharmaceuticals Ltd. | 21.80 |
20 | Montelukast and Acebrophylline (SR) Tablets | Each uncoated bilayered tablet contains: Montelukast Sodium IP eq. to Montelukast 10mg Acebrophylline 200mg (As sustained release) | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Apex Laboratories Private Limited | 17.54 |
21 | Atorvastatin and Fenofibrate | Each film-coated tablet contains: | 1 Tablet | M/s Skymap Pharmaceuticals | 15.93 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 10mg Fenofibrate IP 160mg | Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | |||
22 | Calcium & Vitamins Tablet | Each film-coated tablet contains: Calcium Carbonate IP (From Coral Grains) eq. to Elemental Calcium 500mg Vitamin D3 IP (As Stabilised) 2000 IU Methylcobalamin IP 1500mcg L-Methylfolate Calcium USP 1mg Pyridoxal 5 Phosphate 20mg | 1 Tablet | M/s Premier Nutraceuticals Pvt. Ltd. / M/s Zuventus Healthcare Limited | 18.87 |
23 | Cefpodoxime & Potassium Clavulanate Tablets | Each film-coated tablet contains: Cefpodoxime Proxetil IP eq. to Anhydrous Cefpodoxime 200mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg | 1 Tablet | M/s Saitech Medicare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 28.49 |
24 | Levetiracetam Extended- release Tablets | Each film coated Extended- release tablet contains: Levetiracetam IP 1000mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Ltd. | 33.37 |
25 | Aceclofenac and Paracetamol tablets | Each film-coated tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Stedman Pharmaceuticals Pvt. Ltd. | 5.14 |
26 | Linagliptin and Metformin Hydrochloride Tablet | Each film-coated tablet contains: Linagliptin 2.5mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 8.56 |
27 | Paracetamol, Phenylephrine HCl & Chlorpheniramine ne Maleate Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine HCl IP 10mg Chlorpheniramine Maleate IP 2mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd./ M/s Blue Cross Laboratories Private Limited | 3.57 |
28 | Moxifloxacin hydrochloride & Dexamethasone Phosphate Eye Drops | Composition: Moxifloxacin hydrochloride IP eq. to Moxifloxacin 0.5%w/v Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1% w/v | 1 ml | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 23.27 |
29 | Trypsin- | Each Film Coated Tablet | 1 Tablet | M/s Synokem | 14.21 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Chymotrypsin, Paracetamol, and Aceclofenac Tablets | contains: 150000 Armour Units Enzymatic Activity (Supplied By a Purified Concentrate Which Has Specific Trypsin & Chymotrypsin Activity In a Ratio Of Approximately Six To One) (As Enteric Coated Granules) Paracetamol IP 325 mg Aceclofenac IP 100 mg | Pharmaceuticals Ltd. / M/s Troikaa Pharmaceuticals Limited | |||
30 | Chlorphenirami ne Maleate & Phenylephrine Hydrochloride Syrup | Each 5ml contains: Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg | 1 ml | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Apex Laboratories Private Limited | 1.22 |
31 | Vildagliptin and Metformin Hydrochloride Tablet | Each film-coated tablet contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 8.43 |
32 | Vildagliptin and Metformin Hydrochloride Tablet | Each film-coated tablet contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 8.04 |
33 | Sitagliptin Phosphate and Metformin Hydrochloride tablets | Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 9.13 |
34 | Sitagliptin Phosphate and Metformin Hydrochloride tablets | Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 10.39 |
35 | Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine Hydrochloride & Folic Acid Tablets | Each film-coated tablet contains: Methylcobalamin IP 1500mcg Alpha Lipoic Acid IP 100mg Vitamin D3 IP 1000IU Pyridoxine Hydrochloride IP 3mg Folic Acid IP 1.5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Blue Cross Laboratories Private Limited | 8.03 |
36 | Tranexamic Tablets | Each film-coated tablet contains: | 1 Tablet | M/s Emcure Pharmaceuticals | 30.06 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Tranexamic Acid IP 1000mg | Limited | ||||
37 | Ceftriaxone and Tazobactam injection | Each combi pack contains: Part-I Ceftriaxone and Tazobactam for Injection 1125mg Each vial contains Ceftriaxone Sodium IP (Sterile) eq. to Ceftriaxone 1gm, Tazobactam Sodium IP (Sterile) eq. to Tazobactam 125mg Part-II (For Reconstitution) Each FFS Ampoule contains: Sterile Water for Injection IP 10ml | 1 Vial | M/s East African (India) Overseas / M/s Softdeal Pharmaceuticals Private Limited | 189.45 |
38 | Telmisartan & Cilnidipine Tablet | Each film-coated bilayered tablet contains: Telmisartan IP 40mg and Cilnidipine IP 10mg | 1 Tablet | M/s Windlas Biotech Ltd. (Plant 2) / M/s Emcure Pharmaceuticals Limited | 10.39 |
39 | Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains: Diclofenac Sodium IP 50mg, Paracetamol IP 325mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Softdeal Pharmaceuticals Private Limited | 4.99 |
40 | Vitamin D3 (Cholecalciferol) Oral Drops | Each ml contains: Vitamin D3 (Cholecalciferol) 800IU | 1 ml | M/s SAF Fermion Limited | 5.53 |
41 | Telmisartan & Chlorthalidone Tablet | Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone 6.25mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 5.35 |
42 | Telmisartan & Chlorthalidone Tablet | Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone 12.50mg | 1 Tablet | M/s Akums Drugs and Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 6.25 |
43 | Itraconazole Capsules 130mg (Supra- Bioavailable Formulation) | Each hard gelatin capsule contains: Itraconazole BP 130mg | 1 Capsule | M/s Synokem Pharmaceuticals Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd. | 19.50 |
44 | Linagliptin, Metformin Hydrochloride | Each film coated bilayered tablet contains: Linagliptin 5mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Torrent | 13.03 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
(Extended Release) Tablets | Metformin Hydrochloride IP 500mg (As Extended Release) | Pharmaceuticals Ltd. | |||
45 | Linagliptin, Metformin Hydrochloride (Extended Release) Tablets | Each film coated bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 1000mg (As Extended Release) | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Mankind Pharma Limited | 14.65 |
46 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited | 14.65 |
47 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Pharma Ltd. | 14.44 |
48 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Alkem Laboratories Limited | 14.65 |
49 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 14.65 |
50 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Lupin Limited | 14.44 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Glimepiride IP 1 mg | |||||
51 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Medley Pharmaceuticals Ltd. | 14.44 |
52 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited | 16.33 |
53 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Pharma Ltd. | 16.12 |
54 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Alkem Laboratories Limited | 16.33 |
55 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 16.33 |
56 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Lupin Limited | 16.12 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
release) Glimepiride IP 2 mg | |||||
57 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Medley Pharmaceuticals Ltd. | 16.12 |
58 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 12.00 |
59 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Alkem Laboratories Limited | 13.35 |
60 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Intas Pharmaceuticals Ltd. | 13.00 |
61 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 14.00 |
62 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. /M/s Alkem Laboratories Limited | 15.03 |
63 | Sitagliptin Phosphate, | Each film coated tablet contains: | 1 Tablet | M/s Synokem Pharmaceuticals | 15.00 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin Hydrochloride and Glimepiride Tablets | Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg | Ltd. /M/s Intas Pharmaceuticals Ltd. | |||
64 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (As Extended release) Glimepiride IP 1 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 13.24 |
65 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 14.75 |
66 | Dapagliflozin, Metformin Hydrochloride (Extended Release) and Glimepiride Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (As Extended release) Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Alkem Laboratories Limited | 14.92 |
67 | Trypsin, Bromelain, Rutoside Trihydrate and Diclofenac Sodium Tablets | Each enteric coated tablet contains: Trypsin BP 48mg Bromelain 90mg Rutoside Trihydrate BP 100mg Diclofenac Sodium IP 50mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Neon Laboratories Limited | 21.80 |
68 | Diclofenac Diethylamine, Methyl Salicylate & Menthol Topical Spray | Composition: Diclofenac Diethylamine IP 2.32% w/w (eq. to Diclofenac Sodium 2% w/w), Methyl Salicylate IP 10% w/w, Menthol IP 5% w/w | 1 gram | M/s Pontika Aerotech Limited / M/s Cadila Pharmaceuticals Ltd. | 3.12 |
69 | Tranexamic Acid Tablet | Each film coated tablet contains: Tranexamic Acid IP 250mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Sun Pharmaceutical Industries Limited | 18.43 |
The Notification further added:
- The manufacturer of the above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
- The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
- The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The above-mentioned retail price applies only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
- In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued before this notification, stand(s) superseded.
Also Read:NPPA Fixes Ceiling Price Of 6 Scheduled Formulations, Details
To view the official notice, click the link below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd